KVUE
Kenvue Inc
$19.17
0.22 (1.16%) Today
0.03 (0.16%) After-hours
— up— down
Market Cap
$36.46B-11.6%
Revenue (TTM)
$15.38B+1.8%
Net Income (TTM)
$1.66B+17.2%
EPS (TTM)
0.86+17.2%
Shares Out
1.92B
1.92BP/E Ratio
22.05
22.05Forward P/E
15.77
15.77Dividend
$0.83 (4.43%)
$0.83 (4.43%)Ex-Dividend Date
Aug 12, 2026
Aug 12, 2026Open
$19.02
$19.02Previous Close
$18.98
$18.98Day Range
$19.02 – $19.29
$19.02 – $19.2952-Week Range
$14.02 – $21.85
$14.02 – $21.85Beta
0.45
0.45Volume
10.40M
10.40MAvg Volume
20.05M
20.05MAnalyst Rating
Hold
HoldExchange
NEW YORK STOCK EXCHANGE, INC.
NEW YORK STOCK EXCHANGE, INC.About KVUE
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
Related
News
N/A
N/AN/AN/A
Kenvue Q2 Deep Dive: Assessing Financial Metrics & Growth Prospects
Yahoo · 1d ago

Kimberly-Clark: Temporary Headwinds, Strong Innovation And Kenvue Synergies Support A Buy
SeekingAlpha · 1d ago
UBS Maintains Neutral on Kenvue, Lowers Price Target to $19
Benzinga · 2d ago
How Reddit and Wall Street See Kenvue as Buyout Nears
Yahoo · 6d ago
Kenvue Stock Falls 2.7% as Growth Arrives With Thinner Margins
Yahoo · 1w ago